| Preferred Name |
Tavaborole |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81725 |
| CAS_Registry |
174671-46-6 |
| Chemical_Formula |
C7H6BFO2 |
| code |
C81725 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A boron-containing small molecule antifungal agent with broad-spectrum activity against filamentous fungi, including both mold and yeast. 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole inhibits fungal cytoplasmic leucyl-tRNA synthetase by preventing catalytic turnover, thus inhibiting synthesis of leucyl-tRNA(Leu) and consequentially blocking protein synthesis. |
| FDA_UNII_Code |
K124A4EUQ3 |
| FULL_SYN |
TAVABOROLE Tavaborole AN2690 5-Fluoro-1,3-Dihydro-1-Hydroxy-2,1-Benzoxaborole |
| label |
Tavaborole |
| Legacy Concept Name |
_5-Fluoro-1_3-Dihydro-1-Hydroxy-2_1-Benzoxaborole |
| Preferred_Name |
Tavaborole |
| prefixIRI |
Thesaurus:C81725 |
| prefLabel |
Tavaborole |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C3642427 |
| subClassOf |